With the COVID-19 pandemic making clear the urgent need to speed approvals and enable flexibility in pricing of innovative biopharmaceutical products, regulators in India have drafted a new set of measures to streamline innovative drug research and development. Released in draft form... Read More
This article was originally published on MedTech Intelligence. China’s medical device market has grown tremendously over the last five years. While estimates vary on the total size (somewhere around $50 billion), many foreign companies have grown their business there. Accounting for about... Read More
This article was originally published on MedTech Intelligence. Japan is still the third largest medical device market in the world, after the United States and China. Many global device companies have established good businesses there and are making good profits. Foreign device... Read More
Racing to keep up with the challenges of a fast-expanding biotech sector, China’s regulators are beginning to erect guardrails on how startups can develop, test, and register new drugs. Since September, the National Medical Products Administration (NMPA) has issued more than 15... Read More
As medical software to treat, diagnose, cure or prevent disease becomes more developed, Korean regulators are increasingly approving clinical trials of such Software as a Medical Device (SaMD) technologies. Last year, the country’s Ministry of Food and Drug Safety approved 21 SaMD... Read More
Fueled in part by increased demand as a result of the COVID-19 pandemic, the market for medical devices in India is expected to ramp up over the next four years at a rapid clip, according to a report from data analytics firm... Read More
Chinese biotechnology firms have lagged behind their competitors for years in the use of artificial intelligence technologies. But increasingly, regulatory reforms are making it easier and cheaper for pharmaceutical companies in China to harness a vast trove of data collected from Chinese... Read More
Seeking to topple long-standing obstacles to drug innovation in Japan, pharmaceutical industry leaders in the country have outlined a slate of steps they propose the government take to foster research and development of new products, trim regulations and approval times, and speed... Read More
Advances in the use of artificial intelligence (AI) are fueling significant improvements in the field of radiology in Singapore, South Korea, and Australia, a new study has found. Eight in ten radiologists surveyed by health data firm Royal Phillips this year... Read More
Three major groups representing pharmaceutical companies doing business in Japan are pushing back publicly at what they call plans by regulators to impose onerous new price controls and regulations that would make it harder for them to bring much-needed drugs to market, ... Read More